3,4-Methylenedioxy-N-isopropylamphetamine

MDIP
Clinical data
Other names	3,4-Methylenedioxy-N-isopropylamphetamine; MDIP; MDIPA
Routes of; administration	Oral
ATC code	None;
Pharmacokinetic data
Duration of action	Unknown
Identifiers
	IUPAC name 1-(2H-1,3-benzodioxol-5-yl)-N-(propan-2-yl)propan-2-amine;
CAS Number	74698-37-6 ;
PubChem CID	3057996;
ChemSpider	2319184;
UNII	307EH7224K;
CompTox Dashboard (EPA)	DTXSID40388899 ;
Chemical and physical data
Formula	C13H19NO2
Molar mass	221.300 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1=C2C(=CC=C1CC(C)NC(C)C)OCO2;
	InChI InChI=1S/C13H19NO2/c1-9(2)14-10(3)6-11-4-5-12-13(7-11)16-8-15-12/h4-5,7,9-10,14H,6,8H2,1-3H3; Key:XKEVWMVUIDDRMC-UHFFFAOYSA-N;
	(verify)

3,4-Methylenedioxy-N-isopropylamphetamine (MDIP, MDIPA) is a psychoactive drug of the phenethylamine and amphetamine families.^[1] It is the N-isopropyl analogue of 3,4-methylenedioxyamphetamine (MDA).^[1] MDIP was first synthesized by Alexander Shulgin.^[1] In his book PiHKAL, the minimum dose is listed as 250 mg.^[1] MDIP produces a mild threshold.^[1] Very little is known about the pharmacology, pharmacokinetics, effects, and toxicity of MDIP.^[1]

References